文献速递肿瘤 PET/CT

FDG PET与CT影像组学预测恶性胸膜间皮瘤患者结局的比较

FDG PET versus CT radiomics to predict outcome in malignant pleural mesothelioma patients.
PubMed 文献 · EJNMMI Res · 2020-07-13

本研究基于2009至2017年间在本机构接受根治性手术的72例恶性胸膜间皮瘤患者,利用治疗前FDG PET和CT影像提取影像组学特征建模,预测无进展生存期和总生存期。FDG PET影像组学模型在训练队列(n=36)和内部验证队列(n=36)中预测PFS的c-index分别为0.67(95%CI 0.52-0.82)和0.66(95%CI 0.57-0.78),低风险组的PFS优势也转化为OS优势;CT影像未能训练出影像组学模型,SUVmax和SUVmean亦无预后价值。

要点

  • FDG PET影像组学模型可预测恶性胸膜间皮瘤根治性术后的无进展生存期。
  • 训练队列PFS的c-index为0.67(95%CI 0.52-0.82),内部验证队列为0.66(95%CI 0.57-0.78)。
  • CT影像未能训练出影像组学模型,SUVmax和SUVmean对PFS和OS均无预后价值。

核心结论

  • 作者成功建立了FDG PET影像组学模型用于预测恶性胸膜间皮瘤患者的无进展生存期,影像组学未来可能作为辅助临床决策支持系统的工具。

研究设计与样本

  • 本研究基于2009至2017年间在本机构接受根治性手术的72例恶性胸膜间皮瘤患者,利用治疗前FDG PET和CT扫描进行影像组学结局建模。
  • 从每幅图像提取1404个CT特征和1410个FDG PET特征,经主成分分析预选后纳入Cox回归预测无进展生存期和总生存期,结果在独立队列中验证。

主要发现

  • FDG PET影像组学模型预测PFS的c-index在训练队列(n=36)为0.67(95%CI 0.52-0.82),在内部验证队列(n=36)为0.66(95%CI 0.57-0.78)。
  • 低风险组的PFS优势也转化为OS优势。
  • CT图像未能训练出影像组学模型,SUVmax和SUVmean对PFS和OS亦无预后价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Careful selection of malignant pleural mesothelioma (MPM) patients for curative treatment is of highest importance, as the multimodal treatment regimen is challenging for patients and harbors a high risk of substantial toxicity. Radiomics-a quantitative method for image analysis-has shown its prognostic ability in different tumor entities and could therefore play an important role in optimizing patient selection for radical cancer treatment. So far, radiomics as a prognostic tool in MPM was not investigated. MATERIALS AND METHODS: This study is based on 72 MPM patients treated with surgery in a curative intent at our institution between 2009 and 2017. Pre-treatment Fluorine-18 fluorodeoxyglucose (FDG) PET and CT scans were used for radiomics outcome modeling. After extraction of 1404 CT and 1410 FDG PET features from each image, a preselection by principal component analysis was performed to include only robust, non-redundant features for the cox regression to predict the progression-free survival (PFS) and the overall survival (OS). Results were validated on a separate cohort. Additionally, SUVmax and SUVmean, and volume were tested for their prognostic ability for PFS and OS. RESULTS: For the PFS a concordance index (c-index) of 0.67 (95% CI 0.52-0.82) and 0.66 (95% CI 0.57-0.78) for the training cohort (n = 36) and internal validation cohort (n = 36), respectively, were obtained for the PET radiomics model. The PFS advantage of the low-risk group translated also into an OS advantage. On CT images, no radiomics model could be trained. SUV max and SUV mean were also not prognostic in terms of PFS and OS. CONCLUSION: We were able to build a successful FDG PET radiomics model for the prediction of PFS in MPM. Radiomics could serve as a tool to aid clinical decision support systems for treatment of MPM in future.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Pavic M, Bogowicz M, Kraft J, et al. FDG PET versus CT radiomics to predict outcome in malignant pleural mesothelioma patients. EJNMMI Res. 2020. PMID: 32661672. doi:10.1186/s13550-020-00669-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。